Longmont, CO, United States of America

Connor James Cowdrey

USPTO Granted Patents = 1 

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Spotlight on Inventor Connor James Cowdrey

Introduction

Connor James Cowdrey is an accomplished inventor based in Longmont, Colorado. With a passion for innovation in the pharmaceutical field, Cowdrey has made significant contributions to medical science, particularly in the realm of cancer treatment. His inventive work is recognized within the industry, particularly through his patent.

Latest Patents

Connor James Cowdrey holds one notable patent for 3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors. This invention pertains to a compound of Formula I, or a pharmaceutically acceptable salt thereof, with specific substituents denoted by R, R, R, and R as defined in the patent documentation. Additionally, the invention encompasses pharmaceutical compositions comprising these compounds and salts. It highlights methods and applications for treating abnormal cell growth, including cancer, in subjects in need. Furthermore, it discusses solid forms of the compound 8-((2-fluoro-4-(methylthio)phenyl)amino)-2-(2-hydroxyethoxy)-7-methyl-3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-dione.

Career Highlights

Connor Cowdrey is associated with Pfizer Corporation, a leading global pharmaceutical company, where he applies his expertise in drug development. His work focuses on creating innovative treatments that can potentially improve patient outcomes.

Collaborations

Throughout his career, Cowdrey has collaborated with talented colleagues, including Shelley Allen and Patrick Michael Doerner Barbour. These partnerships foster a dynamic work environment that encourages the sharing of ideas and advancements aimed at combating serious health conditions.

Conclusion

In summary, Connor James Cowdrey stands out as a dedicated inventor making strides in the field of pharmaceuticals. His patent, focused on combating cancer through innovative compounds, underlines his commitment to advancing medical science for the benefit of patients. His collaborations and work at Pfizer Corporation position him as a significant contributor to ongoing efforts in innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…